Trials / Unknown
UnknownNCT04817046
Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)
Detection of Early-stage Lung Cancer Based on Liquid Biopsy of Peripheral Blood: a Prospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 467 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to develop a lung cancer diagnosis tool using a multi-omics approach based on liquid biopsy.
Detailed description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening process to determine eligibility of study entry. Peripheral blood, tissue sample and imaging examinations of eligible patients will be collected for further analysis. Data collected will be used to develop a multi-omics lung cancer diagnosis model.
Conditions
Timeline
- Start date
- 2021-02-19
- Primary completion
- 2022-12-31
- Completion
- 2024-12-31
- First posted
- 2021-03-25
- Last updated
- 2021-03-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04817046. Inclusion in this directory is not an endorsement.